Abbott, Enanta report HCV data

Abbott Laboratories (NYSE:ABT) and partner Enanta Pharmaceuticals Inc. (Cambridge, Mass.) said once-daily ABT-450 plus Norvir ritonavir significantly reduced mean HCV RNA levels from baseline to day t...